Skip to main content
Log in

The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Tumor biomarkers commonly used for the detection of hepatocellular carcinoma (HCC) complicated with portal vein tumor thrombosis (PVTT) do not show satisfactory sensitivity and specificity. This study assesses the diagnostic value of the tumor biomarkers for the diagnosis of HCC with PVTT. A retrospective study was conducted on 475 patients diagnosed as HCC with PVTT and 977 patients diagnosed with HCC by imaging and requiring surgery at our hospital from January 1993 to January 2011. Serum alpha-fetoprotein AFP, carcinoembryonic antigen, and cancer antigen 125 (Ca125) of the patients were studied. No significant differences were observed in the patients’ general characteristics. The receiver operating characteristic (ROC) analysis showed that the cut-off of AFP and Ca125 was 32.91 ng/ml and 113.65 U/ml, respectively (AUC = 0.814 and 0.783). The parallel testing with AFP and Ca125 has a sensitivity of 0.909 and a specificity of 0.410; the serial testing has a sensitivity of 0.520 and a specificity of 0.97. The condition of AFP ≥ 20,000 ng/ml can detect HCC with PVTT with a sensitivity of 0.24, a specificity of 0.96, and an accuracy of 0.73 and positive screening of 0.76. The standard of both AFP > 32.91 ng/ml and Ca125 > 113.65 U/ml or AFP ≥ 20,000 ng/ml can detect HCC with PVTT with a specificity of 0.97 and 0.96, respectively, providing important guidance for clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kim, J. M., Kwon, C. H., Joh, J. W., Park, J. B., Ko, J. S., Lee, J. H., et al. (2013). The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. World Journal of Surgical Oncology, 11, 40. doi:10.1186/1477-7819-11-40.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Lau, W. Y. (2002). Management of hepatocellular carcinoma. Journal of the Royal College of Surgeons of Edinburgh, 47(1), 389–399.

    CAS  PubMed  Google Scholar 

  3. Aizawa, Y., Shibamoto, Y., Takagi, I., Zeniya, M., & Toda, G. (2000). Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Cancer, 89(1), 53–59.

    Article  CAS  PubMed  Google Scholar 

  4. Cohen, J., Edelman, R. R., & Chopra, S. (1992). Portal vein thrombosis: A review. American Journal of Medicine, 92(2), 173–182.

    Article  CAS  PubMed  Google Scholar 

  5. Minagawa, M., & Makuuchi, M. (2006). Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World Journal of Gastroenterology, 12(47), 7561–7567.

    CAS  PubMed  Google Scholar 

  6. Llovet, J. M., Bustamante, J., Castells, A., Vilana, R., Ayuso Mdel, C., Sala, M., et al. (1999). Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials. Hepatology, 29(1), 62–67. doi:10.1002/hep.510290145.

    Article  CAS  PubMed  Google Scholar 

  7. Shi, J., Lai, E. C., Li, N., Guo, W. X., Xue, J., Lau, W. Y., et al. (2010). Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Annals of Surgical Oncology, 17(8), 2073–2080. doi:10.1245/s10434-010-0940-4.

    Article  PubMed  Google Scholar 

  8. Hoekstra, J., & Janssen, H. L. (2009). Vascular liver disorders (II): Portal vein thrombosis. The Netherlands Journal of Medicine, 67(2), 46–53.

    CAS  PubMed  Google Scholar 

  9. Cheng, S., Wu, M., & Cheng, H. (2003). Growing features of the tumor thrombus of portal vein in hepatocellular carcinoma: Report of 130 cases. Chinese Journal of Current Advances in General Surgery, 6, 103–105.

    Google Scholar 

  10. Fan, J., Wu, Z., & Zhou, J. (2000). Comparison of several therapeutic methods for hepatocellular carcinoma with tumor thrombi in portal vein. Chinese Journal of Oncology, 22, 247–249.

    CAS  Google Scholar 

  11. Xue, F., Shen, F., & Wu, M. (2005). The progress in diagnosis and treatment for hepatocellular carcinoma with portal vein tumor thrombus. Chinese Oncology, 14, 148–152.

    Google Scholar 

Download references

Acknowledgments

This work was supported by the National Key Technology R&D Program of China (2012BI06B01) and the National S&T Major Project for Infectious Diseases of China (2012ZX10002-017).

Conflict of interest

Authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Kai Jiang or Jiahong Dong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Wang, X., Jiang, K. et al. The Diagnostic Value of Tumor Biomarkers for Detecting Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombosis. Cell Biochem Biophys 69, 455–459 (2014). https://doi.org/10.1007/s12013-014-9817-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-9817-7

Keywords

Navigation